Treatment
Treatment clinical trials
We’re tracking 8,310 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07398677Recruiting
SchoolCare: Helping kids with cancer stay connected to school
This study tests if a telepresence robot and a school navigator can help children with cancer stay engaged with their school during long treatments. It aims to reduce school disruption and social isolation.
AalborgAges 5–17 - NCT07400510Enrolling by invitation
Ultrasound for DVT diagnosis and treatment
This trial uses a bedside ultrasound to quickly diagnose deep vein thrombosis (DVT) and help guide treatment. It may help patients who have symptoms like leg swelling or pain.
Hershey, PennsylvaniaAges 18 years+ - NCT07399977Recruiting
Blood test to guide blood thinner use in cancer
This study tests whether a blood test and computer program can help doctors decide how long you need to take blood thinners after a cancer-related blood clot. If you've been on a blood thinner for a few months and have certain cancers, this trial may offer a more personalized approach.
Basking Ridge, New JerseyAges 18 years+ - NCT07400536RecruitingPhase 3
Cadonilimab plus chemo and radiation for advanced cervical cancer
This trial tests a new immunotherapy drug, cadonilimab, combined with standard chemotherapy followed by chemoradiation for locally advanced cervical cancer. The goal is to see if this combination works better than current treatments.
Wuhan, HubeiAges 18–70 - NCT07404397RecruitingPhase 2/Phase 3
Treatments for chronic pelvic pain with high muscle tone
This study compares two treatments for chronic pelvic pain caused by tight pelvic floor muscles: a daily muscle relaxant pill (cyclobenzaprine) or a vibrating massage wand. The goal is to see which works better alongside pelvic floor physical therapy.
Ann Arbor, MichiganAges 18–65 - NCT07402031Recruiting
Predicting weight loss from obesity treatments
This study looks at how people lose weight after medication or surgery for obesity. It helps predict which treatment might work best for you.
Brussels, Brussels CapitalAges 18–65 - NCT07401420Recruiting
Study on life-sustaining treatments in critically ill children
This study asks experienced critical care doctors about decisions they make when providing life-sustaining treatments to critically ill children, especially around end-of-life care. Your insights could help improve how these difficult situations are handled.
GothenburgAges 18 years+ - NCT07405086RecruitingPhase 4
Morning versus afternoon immunotherapy for advanced cancer
This trial tests whether getting your immunotherapy infusion in the morning or in the afternoon makes any difference in how well it works. If you have certain types of advanced cancer and are about to start a standard FDA-approved immunotherapy, this study may help you and others by finding the best time of day for treatment.
Portland, OregonAges 18 years+ - NCT06826898Recruiting
Hydrogel to prevent scar tissue after ankle ligament repair
This trial tests a special gel placed during ankle ligament repair surgery to see if it prevents painful scar tissue from forming. It might help people with chronic ankle sprains who need surgery.
ChanghuaAges 18–60 - NCT06827249Recruiting
Testing peginterferon for RSV lung infection in young children
This trial tests a medication called peginterferon to treat RSV bronchiolitis (a lung infection causing wheezing and breathing trouble) in children ages 6 months to 2 years. It aims to see if the drug helps them recover faster.
Wuhan, HubeiAges 6 months–2 years - NCT04711551Recruiting
Monitoring patients after regenerative treatments for joint or tendon pain
This trial follows people who receive “regenerative medicine” treatments (orthobiologics) for joint or tendon problems, like osteoarthritis or tendon pain. The goal is to study whether clinical check-ins and lab/biologic measurements can help monitor how patients are doing after treatment.
Milan, ItaliaAges 6 years+ - NCT06282445RecruitingPhase 2
Combination therapy for first-line metastatic colorectal cancer
This trial tests whether adding the immunotherapy drug adebrelimab to standard chemotherapy plus bevacizumab can help people with a specific type of metastatic colorectal cancer that cannot be removed by surgery. It is for patients whose tumors are microsatellite stable (MSS) or have normal mismatch repair (pMMR).
Jinhua, ZhejiangAges 18–75 - NCT06356662RecruitingPhase 1
Testing tenofovir for Parkinson's disease
This trial is testing if a medicine called tenofovir, usually used for HIV and hepatitis B, can help people with early-stage Parkinson's disease. It's for people who are under 65 and have no other major health issues.
Hangzhou, ZhejiangAges 18–65 - NCT06492083Recruiting
Hot pack treatment for nerve pain from chemo
This study tests if a traditional Chinese medicine hot pack can help reduce nerve pain caused by chemotherapy drugs like platinum and paclitaxel. It also looks at how to best care for patients during this treatment.
Yiwu, ZhejiangAges 18 years+ - NCT06487741Recruiting
Stretching at home for fibromyalgia pain relief
This study tests whether a simple home stretching program can help relieve fibromyalgia symptoms. You would be asked to do stretches at home and report how you feel.
AalborgAges 18–60 - NCT06819826RecruitingPhase 3
Study of SC0062 for IgA Nephropathy with Proteinuria
This trial tests an experimental drug (SC0062 capsule) for people with IgA nephropathy who have protein in their urine. It aims to see if the drug can help reduce kidney damage when added to standard treatments like blood pressure medications.
Guangzhou, Yuexiu DistrictAges 18 years+ - NCT07396636Recruiting
Using machine learning to manage low blood pressure during surgery
This study tests whether an AI tool can help doctors better manage low blood pressure during planned surgeries. If you are having an elective surgery with general anesthesia and need an arterial line for monitoring, this trial may be for you.
Konya, Konya/MeramAges 18 years+ - NCT07392736RecruitingPhase 1/Phase 2
Study of AL8326 plus Toripalimab for advanced solid tumors
This trial tests a new combination of two drugs (AL8326 and Toripalimab) for people with advanced solid tumors that have stopped responding to standard treatments or have no other options. The goal is to see if the combination is safe and shrinks tumors.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07395232RecruitingPhase 3
Treatment for allergic eye disease
This trial tests a new eye drop to reduce itching and other symptoms of allergic conjunctivitis, a condition where the eyes become red, itchy, and uncomfortable due to allergies. It may help people who have not found relief with current treatments.
Jacksonville, FloridaAges 10–65 - NCT07393360Recruiting
Muscle preservation during weight loss with GLP-1 drugs
This trial tests a special medical food to help keep muscle mass while losing weight with GLP-1 medications like liraglutide, semaglutide, or tirzepatide. It's for adults with obesity or overweight with related health issues.
MilanAges 18–65 - NCT07393659RecruitingPhase 3
Continued access to HIV treatment after a parent study
This study lets people who finished an earlier HIV treatment study keep getting the same medicine while a new trial is set up. It helps ensure you don't have a gap in your treatment.
Durban, KwaZulu-NatalAges Any age - NCT07391813RecruitingPhase 1/Phase 2
Testing SNB-101 for advanced small cell lung cancer
This study tests a new drug, SNB-101, for people with small cell lung cancer that has spread and has worsened after standard therapy. It aims to find out if SNB-101 can help control the cancer and what side effects it may cause.
KamenitzAges 18 years+ - NCT07392333Recruiting
Nerve ablation for chronic low back pain
This study tests a treatment that uses radiofrequency energy to target specific nerves in the spine that may be causing your low back pain. If you qualify, you would receive the OptaBlate BVN procedure and be followed over time to see how well it works.
Fort Lauderdale, FloridaAges 22 years+ - NCT07397325RecruitingPhase 1/Phase 2
Study of a cooling cap to prevent hair loss from chemo
This trial tests a cooling cap (DA-020) to see if it can prevent hair loss during breast cancer chemotherapy. It may help you keep more of your hair while getting treatment.
ManausAges 18–65
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,310 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.